Free Trial Information
BioCentury | Jan 14, 2008
Clinical News

Tissera preclinical data

...near-normal blood sugar levels. Animals were completely independent of exogenous insulin at 5 months post-transplant. Tissera Inc....
Read More
BioCentury | Mar 27, 2006
Clinical News

Tissera preclinical data

...significant proliferation of the transplanted cells. In addition, no signs of host rejection were detected. Tissera Inc....
Read More
BioCentury | Apr 26, 2004
Company News

Tissera scientific advisory board update

Tissera Inc. (TSSR), Tel Aviv, Israel Business: Transplant Appointed: Giuseppe Remuzzi, director of the Mario Negri Institute for Pharmacological Research; Sir Roy Caln, professor of surgery at the National University of Singapore WIR Staff...
Read More
BioCentury | Apr 19, 2004
Company News

Tissera scientific advisory board update

Tissera Inc. (TSSR), Tel Aviv, Israel Business: Transplant Appointed: Abraham Shaked, professor of surgery at the University of Pennsylvania WIR Staff Transplant...
Read More
BioCentury | Feb 23, 2004
Company News

Tissera management update

Tissera Inc. (TSSR), Tel Aviv, Israel Business: Transplant Hired: Vicki Rabenou as CEO, formerly president and CEO of the Rad BioMed Incubator WIR Staff Transplant...
Read More
BioCentury | Feb 19, 2004
Company News

Tissera hires Rabenou as CEO

...Vicki Rabenou as CEO. Previously, Rabenou was president and CEO of the Rad BioMed Incubator. Tissera...
Read More
Items per page:
1 - 6 of 6
BioCentury | Jan 14, 2008
Clinical News

Tissera preclinical data

...near-normal blood sugar levels. Animals were completely independent of exogenous insulin at 5 months post-transplant. Tissera Inc....
Read More
BioCentury | Mar 27, 2006
Clinical News

Tissera preclinical data

...significant proliferation of the transplanted cells. In addition, no signs of host rejection were detected. Tissera Inc....
Read More
BioCentury | Apr 26, 2004
Company News

Tissera scientific advisory board update

Tissera Inc. (TSSR), Tel Aviv, Israel Business: Transplant Appointed: Giuseppe Remuzzi, director of the Mario Negri Institute for Pharmacological Research; Sir Roy Caln, professor of surgery at the National University of Singapore WIR Staff...
Read More
BioCentury | Apr 19, 2004
Company News

Tissera scientific advisory board update

Tissera Inc. (TSSR), Tel Aviv, Israel Business: Transplant Appointed: Abraham Shaked, professor of surgery at the University of Pennsylvania WIR Staff Transplant...
Read More
BioCentury | Feb 23, 2004
Company News

Tissera management update

Tissera Inc. (TSSR), Tel Aviv, Israel Business: Transplant Hired: Vicki Rabenou as CEO, formerly president and CEO of the Rad BioMed Incubator WIR Staff Transplant...
Read More
BioCentury | Feb 19, 2004
Company News

Tissera hires Rabenou as CEO

...Vicki Rabenou as CEO. Previously, Rabenou was president and CEO of the Rad BioMed Incubator. Tissera...
Read More
Items per page:
1 - 6 of 6